Birmingham, AL, United States of America

Mark Prichard


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Prichard: Innovator in HSV-2 Treatment

Introduction

Mark Prichard is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of HSV-2 infections. His innovative work has the potential to impact many lives.

Latest Patents

Mark Prichard holds 1 patent for his invention titled "Methods and compositions for treatment and prevention of HSV-2 infections." This patent involves live, attenuated, phenotypically stable HSV-2 viruses and methods for their production and use. The recombinant techniques used to construct these viruses allow for their application in pharmaceutical compositions aimed at both prophylactic treatment and the management of recurrent HSV-2 related diseases and conditions.

Career Highlights

Mark Prichard is associated with Medimmune Limited, where he continues to advance his research and development efforts. His work is crucial in the ongoing battle against viral infections, particularly those caused by HSV-2.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Richard R. Spaete and George William Kemble. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Mark Prichard's contributions to the field of HSV-2 treatment exemplify the impact of innovative thinking in medical science. His work not only advances our understanding of viral infections but also offers hope for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…